TrialJournal of Alzheimer's disease : JAD2021

A Precision Medicine Approach to Treating Alzheimer's Disease Using Rosiglitazone Therapy: A Biomarker Analysis of the REFLECT Trials.

Sid E O'Bryant et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.